SEELOS THERAPEUTICS INC (SEEL)
Institutional ownership reported to the SEC as of Q2 2024, across 23 quarters.
23
Reporting holders
$129.7K
Reported value
0.0%
Held as options
-12
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2024 | 23 | $129.7K | 213,969 | 21 | 0 | 2 | 0.0% |
| Q1 2024 | 35 | $1.7M | 2,883,371 | 6 | 12 | 4 | 0.0% |
| Q4 2023 | 37 | $2.8M | 1,856,667 | 36 | 0 | 0 | 7.1% |
| Q3 2023 | 73 | $7.0M | 37,841,613 | 15 | 22 | 15 | 1.0% |
| Q2 2023 | 72 | $25.9M | 21,383,943 | 7 | 17 | 13 | 1.3% |
| Q1 2023 | 69 | $14.0M | 19,967,878 | 10 | 11 | 17 | 1.2% |
| Q4 2022 | 65 | $13.8M | 19,619,568 | 13 | 8 | 16 | 3.2% |
| Q3 2022 | 75 | $28.8M | 27,209,513 | 12 | 17 | 23 | 2.6% |
| Q2 2022 | 73 | $21.8M | 31,330,911 | 17 | 18 | 26 | 2.4% |
| Q1 2022 | 85 | $35.2M | 41,399,732 | 12 | 24 | 29 | 1.8% |
| Q4 2021 | 91 | $71.2M | 40,792,772 | 8 | 33 | 20 | 6.7% |
| Q3 2021 | 106 | $99.8M | 40,810,743 | 23 | 37 | 25 | 1.5% |
| Q2 2021 | 101 | $110.0M | 40,838,763 | 50 | 25 | 17 | 2.0% |
| Q1 2021 | 70 | $127.3M | 25,125,601 | 46 | 13 | 7 | 1.5% |
| Q4 2020 | 27 | $11.9M | 7,496,228 | 10 | 7 | 4 | 0.0% |
| Q3 2020 | 25 | $4.7M | 4,987,437 | 8 | 5 | 5 | 0.0% |
| Q2 2020 | 26 | $4.5M | 4,421,252 | 10 | 5 | 5 | 0.0% |
| Q1 2020 | 21 | $2.5M | 5,186,899 | 8 | 6 | 3 | 0.0% |
| Q4 2019 | 14 | $3.9M | 2,895,519 | 1 | 5 | 4 | 0.0% |
| Q3 2019 | 20 | $3.1M | 3,354,266 | 8 | 6 | 2 | 0.0% |
| Q2 2019 | 15 | $5.9M | 2,676,365 | 8 | 6 | 1 | 0.0% |
| Q1 2019 | 13 | $3.7M | 1,090,319 | 12 | 0 | 1 | 0.0% |
| Q4 2018 | 1 | $86.0K | 456,832 | 0 | 0 | 0 | 0.0% |